Get In Touch
The medical device industry is a global industry. Globalization offers opportunities to increase revenue and decrease costs; it enriches the innovation that drives the industry by enabling collaboration with subject matter experts from across the globe; and it also enables medical device companies to establish global network relationships with suppliers, manufacturing sites, distributors and customers around the world.
It's been widely reported that Hollywood Presbyterian Medical Center experienced a ransomware attack on February 5 that encrypted their data and disabled their network. The hospital was forced to revert to paper and faxes to relay patient information, and hospital operations were so strained that they succumbed to the cyberattack and paid the hackers 40 bitcoins, or about $17,000, to get the decryption key.
Health IT Security recently published the results of Akamai's latest State of the Internet report, emphasizing that "Distributed denial of services (DDoS) attacks are up during the third quarter of 2015, reinforcing the healthcare industry's growing concern for healthcare data security." They have hit on a very salient point here, because while many may think that healthcare providers are not likely targets of DDoS attacks, there are definite reasons why
It's hard to miss all the media attention surrounding data breaches in healthcare. If you're involved in information security at a healthcare organization, it's no surprise to you that more than 143 million individuals have been affected by data breaches since HHS started tracking incidents in September 2009.
While hospitals are ramping up security efforts to protect information, a large percentage of them are vulnerable to attacks on their web sites. Less than two-thirds of hospitals participating in a recent survey reported having on-premise web application firewalls in place, and fewer than half reported having defenses in place to thwart distributed denial of service (DDoS) attacks. Read more here.
A pharmaceutical company decides to go global for a lot of reasons: Perhaps they want to expand into developing markets that are less saturated. Or they may need to conduct global clinical trials to get broader and more diverse participant base.